Differential release of cardiac enzymes after percutaneous coronary intervention

We hypothesized that using calcium channel blockers (CCBs) that dilate microvasculature during percutaneous coronary intervention (PCI) would result in lower postprocedural creatine phosphokinase (CPK). PCI can be complicated by elevated CPK that has been associated with impaired microvascular perfu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Catheterization and cardiovascular interventions 2005-05, Vol.65 (1), p.19-24
Hauptverfasser:	Matthews, Mark A., Kunselman, Susan J., Gascho, Joseph A., Gilchrist, Ian C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Angioplasty, Balloon, Coronary Biomarkers - blood calcium channel blockers Calcium Channel Blockers - administration & dosage Calcium Channel Blockers - therapeutic use coronary arteriosclerosis Coronary Vessels - drug effects Coronary Vessels - physiopathology Creatine Kinase - blood Female Follow-Up Studies Humans Injections, Intra-Arterial Male Middle Aged myocardial infarction Myocardial Ischemia - enzymology Myocardial Ischemia - physiopathology Myocardial Ischemia - therapy Myocardium - enzymology nitroglycerin Nitroglycerin - administration & dosage Nitroglycerin - therapeutic use Prospective Studies Treatment Outcome Vasodilation - drug effects Vasodilator Agents - administration & dosage Vasodilator Agents - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!